POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $624,979 | -26.4% | 93,700 | 0.0% | 0.19% | -28.1% |
Q2 2023 | $848,922 | -41.2% | 93,700 | -52.8% | 0.26% | -55.9% |
Q1 2023 | $1,442,928 | -50.6% | 198,477 | -50.5% | 0.60% | -28.7% |
Q4 2022 | $2,921,919 | +26.0% | 400,812 | +33.6% | 0.84% | +6.6% |
Q3 2022 | $2,319,000 | +42.2% | 300,000 | +46.6% | 0.78% | +16.1% |
Q1 2022 | $1,631,000 | +42.4% | 204,679 | +0.1% | 0.68% | +45.5% |
Q4 2021 | $1,145,000 | +107.4% | 204,462 | +185.0% | 0.46% | +48.7% |
Q3 2021 | $552,000 | – | 71,729 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |